GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Omid Holdings Inc (OTCPK:OMID) » Definitions » Earnings Yield (Joel Greenblatt) %

Omid Holdings (Omid Holdings) Earnings Yield (Joel Greenblatt) % : 0.00% (As of . 20)


View and export this data going back to . Start your Free Trial

What is Omid Holdings Earnings Yield (Joel Greenblatt) %?

Omid Holdings's Enterprise Value for the quarter that ended in . 20 was $0.00 Mil. Omid Holdings does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Omid Holdings's Earnings Yield (Joel Greenblatt) at this moment.

The historical rank and industry rank for Omid Holdings's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

OMID's Earnings Yield (Joel Greenblatt) % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.45
* Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Omid Holdings's Forward Rate of Return (Yacktman) % for the quarter that ended in . 20 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Omid Holdings Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for Omid Holdings's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omid Holdings Earnings Yield (Joel Greenblatt) % Chart

Omid Holdings Annual Data
Trend
Earnings Yield (Joel Greenblatt) %

Omid Holdings Quarterly Data
Earnings Yield (Joel Greenblatt) %

Competitive Comparison of Omid Holdings's Earnings Yield (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, Omid Holdings's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omid Holdings's Earnings Yield (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Omid Holdings's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Omid Holdings's Earnings Yield (Joel Greenblatt) % falls into.



Omid Holdings Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Omid Holdingss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in . 20 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=/
= %



Omid Holdings  (OTCPK:OMID) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Omid Holdings Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Omid Holdings's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Omid Holdings (Omid Holdings) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865
Omid Holdings Inc is a health and wellness company. It is specialized in the sale and manufacture of CBD-based products. The company manufactures and sells branded inhalable, sublingual, and topical hemp-derived consumer goods. Its brands include Naturally Peaked Health, Shangri-La Life, and Peac Wellness. The company also offers design, development, manufacturing services to clients in the CBD-based cannabis industry.

Omid Holdings (Omid Holdings) Headlines

From GuruFocus

OMID Provides Fourth-Quarter Financial Highlights

By PRNewswire PRNewswire 01-14-2021

AV1 Group, Inc. Announces LOI

By Marketwired Marketwired 05-08-2019

OMID Provides Third-Quarter Financial Highlights

By PRNewswire PRNewswire 10-12-2021

OMID Holdings Discloses New Corporate Initiatives

By PRNewswire PRNewswire 02-17-2021

OMID Makes Strategic Investment Into Psychedelic Medicine

By PRNewswire PRNewswire 08-12-2021

OMID Reports Strong Second-Quarter Financial Results

By PRNewswire PRNewswire 09-16-2020

OMID Holdings, Inc. Issues Shareholder Letter

By PRNewswire PRNewswire 03-02-2021

OMID Provides Corporate Update

By PRNewswire PRNewswire 01-07-2021

OMID Holdings Completes Share Cancellation

By PRNewswire PRNewswire 01-27-2021